Article Information
History
- September 16, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lauren C Shapiro1,
- Astha Thakkar1,
- Radhika Gali1,
- Jesus D Gonzalez-Lugo1,
- Abdul-Hamid Bazarbachi2,
- Shafia Rahman1,
- Kith Pradhan1,
- Karen Fehn1,
- Michelly Abreu1,
- Noah Kornblum1,
- Kira Gritsman1,
- Mendel Goldfinger1,
- Aditi Shastri1,
- Ioannis Mantzaris1,
- Ira Braunschweig1,
- Balazs Halmos1,
- Amit Verma1,
- Margaret McCort2,
- Lizamarie Bachier-Rodriguez1 and
- R. Alejandro Sica1,*
- 1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA
- 2Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA
- 3Division of Infectious Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA
- ↵*Corresponding Author:
R. Alejandro Sica, MD, Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, P: 718-920-4826, F: 718-798-7474, Email: asica{at}montefiore.org
Posted September 16, 2021.
High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination
